SHANGHAI and CAMBRIDGE, Mass, Nov. 14, 2026 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, today announced that five of its commercial medicines in China have been included in the country's 2026 National Reimbursement Drug List (NRDL). The update includes two first-time listings,...
JAKARTA, Indonesia, Sept. 15, 2025 /PRNewswire/ -- O.NE PEOPLE Co., Ltd., a leading provider of data privacy and security solutions, today announced the signing...